A 55-year-old @entity1 visited our clinic for rapid swelling of her left breast. The left breast was palpated, and a mass of about 10 cm with thick skin, and multiple lymph nodes in the supraclavicle and axilla were found. PET-CT images showed an increased uptake in her left breast, lymph nodes, spine of TH5, sternum, left lobe of liver, and both lungs. The serum @entity5 markers were also found to be elevated. A core needle biopsy was performed, and the @entity5 was diagnosed as secondary inflammatory @entity189 ( @entity513 ). Immunohistochemical staining showed negative for @entity1722 protein, but strongly positive for ER and @entity7273 . @entity4672 monotherapy administered her starting June, 2008. After 3 months, the @entity3 showed a notable response, which was subsequently maintained for 19 months. The @entity5 markers decreased to the normal range after 6 months, and the multiple @entity3 were not found by PET-CT after 1 year. A radiofrequency ablation operation was conducted on the remaining 3 cm @entity0 . Neoadjuvant endocrine therapy with @entity4672 was shown to be useful for post-menopausal @entity0 @entity1 with strong hormone receptor expression.

[A case of secondary inflammatory @entity0 with multiple XXXX in which operation was possible through letrozole monotherapy].

@entity1 :: ('9606', 'Species') :: ['woman', 'patients'] @entity4672 :: ('MESH:C067431', 'Chemical') :: ['letrozole', 'Letrozole'] @entity0 :: ('MESH:D001943', 'Disease') :: ['breast cancer'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity7273 :: ('5241', 'Gene') :: ['PgR'] @entity189 :: ('MESH:D002277', 'Disease') :: ['carcinoma'] @entity513 :: ('MESH:D044584', 'Disease') :: ['invasive ductal carcinoma'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastases'] @entity1722 :: ('2064', 'Gene') :: ['HER2']
@entity3 :: (MESH:D009362,Disease) :: ['metastases']
